Hemophilia A trials in Spain: Trial Insights

Filters: Condition: Hemophilia A Country / region: Spain Clear all

167 trials match Source: ClinicalTrials.gov registrations

Trials started per year
Category	Trials
2002	2
2004	1
2005	2
2006	2
2007	1
2008	2
2009	8
2010	6
2011	6
2012	9
2013	7
2014	10
2015	15
2016	11
2017	6
2018	11
2019	4
2020	11
2021	11
2022	7
2023	11
2024	6
2025	10
2026	7

Trials by status
Category	Trials
Completed	104
Recruiting	15
Active, not recruiting	14
Unknown status	14
Terminated	12
Not yet recruiting	5
Enrolling by invitation	2
Withdrawn	1

Top lead sponsors
Category	Trials
Novo Nordisk A/S	31
Investigación en Hemofilia y Fisioterapia	20
Baxalta now part of Shire	16
Bayer	14
Hoffmann-La Roche	12
Pfizer	10
Swedish Orphan Biovitrum	9
Universidad Católica San Antonio de Murcia	8
Bioverativ, a Sanofi company	4
CSL Behring	4

Top conditions
Category	Trials
Hemophilia A	167
Hemophilia B	26
Blood Coagulation Disorders	11
Coagulation Protein Disorders	10
Arthralgia	9
Joint Diseases	8
Chronic Pain	7
Hematologic Diseases	7
Anxiety Disorders	5
Genetic Diseases, Inborn	5

Trials

Showing 26 to 50 of 167. Each trial links to its page on Pharma Observatory.

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A NCT05987449Phase 1/2RecruitingHoffmann-La RocheStarted 2023
Restricting Blood Flow in Improving Muscle Strength in Patients With Hemophilic Arthropathy NCT05039008Not applicableCompletedInvestigación en Hemofilia y FisioterapiaStarted 2023
An 18-month Low-interventional Study to Assess Joint Health in Haemophilia A and B Patients on Prophylaxis With Efmoroctocog Alfa or Eftrenonacog Alfa NCT05856266Phase 4TerminatedSwedish Orphan BiovitrumStarted 2023
A Study Evaluating Physical Activity and Joint Health in Severe Haemophilia A Patients ≥12 Years Treated Once Weekly With Efanesoctocog Alfa NCT05817812Phase 3CompletedSwedish Orphan BiovitrumStarted 2023
A Study of SerpinPC in Participants with Hemophilia B (HemB) with Inhibitors NCT05789537Phase 2TerminatedApcinteX LtdStarted 2023
The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia B NCT05789524Phase 2TerminatedApcinteX LtdStarted 2023
A Research Study Looking at How Safe it is to Switch From Emicizumab to Mim8 in People With Haemophilia A (FRONTIER 5) NCT05878938Phase 3CompletedNovo Nordisk A/SStarted 2023
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A NCT05685238Phase 3Active, not recruitingNovo Nordisk A/SStarted 2023
A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia NCT05662319Phase 3Active, not recruitingSanofiStarted 2023
A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401) NCT05768386ObservationalEnrolling by invitationBioMarin PharmaceuticalStarted 2023
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively NCT05568719Phase 3RecruitingPfizerStarted 2022
Hemophilia Non-Interventional Study Prior to SerpinPC Intervention (PRESent-5) NCT05605678ObservationalTerminatedApcinteX LtdStarted 2022
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B NCT05611801Phase 3RecruitingPfizerStarted 2022
Manual Therapy in the Treatment of Hemophilic Arthropathy of the Ankle NCT05549843Not applicableCompletedInvestigación en Hemofilia y FisioterapiaStarted 2022
Functional and Proprioceptive Status in Patients With Hemophilic Ankle Arthropathy NCT05425888ObservationalCompletedInvestigación en Hemofilia y FisioterapiaStarted 2022
A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis NCT05181618Phase 4Active, not recruitingHoffmann-La RocheStarted 2022
A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors NCT05135559Phase 3Active, not recruitingNovo Nordisk A/SStarted 2022
A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors NCT05053139Phase 3CompletedNovo Nordisk A/SStarted 2021
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors NCT05145127Phase 3RecruitingPfizerStarted 2021
Self-myofascial Release With Foam Roller in Patients With Hemophilic Knee Arthropathy NCT05108480Not applicableCompletedInvestigación en Hemofilia y FisioterapiaStarted 2021
Movement Visualization in Pain Management in Patients With Hemophilic Arthropathy. NCT04549402Not applicableUnknown statusInvestigación en Hemofilia y FisioterapiaStarted 2021
Study to Learn More About the Physical Activity Level of Patients Suffering From Hemophilia A Treated With Damoctocog Alfa Pegol (LIFE ACTIVE Study) NCT04091386ObservationalCompletedBayerStarted 2021
Rofecoxib Efficacy and Safety Evaluation Trial in Hemophilic Arthropathy NCT04684511Phase 3TerminatedTremeau Pharmceuticals, Inc.Started 2021
Study to Learn More About the Safety of Drug Jivi Over a Long Period of Time in Previously Treated Patients With Hemophilia A (Bleeding Disorder Resulting From a Lack of FVIII) Who Are Receiving Jivi Regularly at Their Treating Doctors to Prevent Bleeding NCT04461639ObservationalActive, not recruitingBayerStarted 2021
Therapeutic Exercise in Patients With Hemophilia NCT04114448Not applicableTerminatedUniversity of SevilleStarted 2021

67 more trials match. See them on Pharma Observatory

Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa NCT06716814Status changeRecruiting to Active, not recruitingOctober 22, 2026
Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa NCT06716814Enrollment change104 to 89October 22, 2026

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.

Visit Pharma Observatory